Sweden · Delayed Price · Currency is SEK BioGaia AB Statistics
Total Valuation
BioGaia AB has a market cap or net worth of SEK 12.04 billion. The enterprise value is 11.26 billion.
| Market Cap | 12.04B |
| Enterprise Value | 11.26B |
Important Dates
The next confirmed earnings date is Friday, July 17, 2026.
| Earnings Date | Jul 17, 2026 |
| Ex-Dividend Date | May 8, 2026 |
Share Statistics
BioGaia AB has 101.16 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 98.50M |
| Shares Outstanding | 101.16M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.52% |
| Owned by Institutions (%) | 35.89% |
| Float | 83.08M |
Valuation Ratios
The trailing PE ratio is 36.18 and the forward PE ratio is 28.67.
| PE Ratio | 36.18 |
| Forward PE | 28.67 |
| PS Ratio | 7.83 |
| PB Ratio | 9.16 |
| P/TBV Ratio | 10.32 |
| P/FCF Ratio | 39.72 |
| P/OCF Ratio | 39.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.62, with an EV/FCF ratio of 37.16.
| EV / Earnings | 33.84 |
| EV / Sales | 7.32 |
| EV / EBITDA | 23.62 |
| EV / EBIT | 24.91 |
| EV / FCF | 37.16 |
Financial Position
The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.12 |
| Quick Ratio | 5.21 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.08 |
| Interest Coverage | 74.62 |
Financial Efficiency
Return on equity (ROE) is 21.91% and return on invested capital (ROIC) is 68.07%.
| Return on Equity (ROE) | 21.91% |
| Return on Assets (ROA) | 15.56% |
| Return on Invested Capital (ROIC) | 68.07% |
| Return on Capital Employed (ROCE) | 32.31% |
| Weighted Average Cost of Capital (WACC) | 6.04% |
| Revenue Per Employee | 6.36M |
| Profits Per Employee | 1.38M |
| Employee Count | 238 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 2.56 |
Taxes
In the past 12 months, BioGaia AB has paid 88.46 million in taxes.
| Income Tax | 88.46M |
| Effective Tax Rate | 21.00% |
Stock Price Statistics
The stock price has increased by +22.12% in the last 52 weeks. The beta is 0.32, so BioGaia AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +22.12% |
| 50-Day Moving Average | 111.55 |
| 200-Day Moving Average | 105.41 |
| Relative Strength Index (RSI) | 62.23 |
| Average Volume (20 Days) | 216,631 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioGaia AB had revenue of SEK 1.54 billion and earned 332.76 million in profits. Earnings per share was 3.29.
| Revenue | 1.54B |
| Gross Profit | 1.13B |
| Operating Income | 451.97M |
| Pretax Income | 421.22M |
| Net Income | 332.76M |
| EBITDA | 468.92M |
| EBIT | 451.97M |
| Earnings Per Share (EPS) | 3.29 |
Balance Sheet
The company has 801.31 million in cash and 23.16 million in debt, with a net cash position of 778.15 million or 7.69 per share.
| Cash & Cash Equivalents | 801.31M |
| Total Debt | 23.16M |
| Net Cash | 778.15M |
| Net Cash Per Share | 7.69 |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 12.99 |
| Working Capital | 1.02B |
Cash Flow
In the last 12 months, operating cash flow was 306.57 million and capital expenditures -3.52 million, giving a free cash flow of 303.04 million.
| Operating Cash Flow | 306.57M |
| Capital Expenditures | -3.52M |
| Depreciation & Amortization | 16.94M |
| Net Borrowing | -6.85M |
| Free Cash Flow | 303.04M |
| FCF Per Share | 3.00 |
Margins
Gross margin is 73.37%, with operating and profit margins of 29.38% and 21.63%.
| Gross Margin | 73.37% |
| Operating Margin | 29.38% |
| Pretax Margin | 27.38% |
| Profit Margin | 21.63% |
| EBITDA Margin | 30.49% |
| EBIT Margin | 29.38% |
| FCF Margin | 19.70% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 3.36%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 3.36% |
| Dividend Growth (YoY) | -42.03% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 59.28% |
| Buyback Yield | -0.09% |
| Shareholder Yield | 3.24% |
| Earnings Yield | 2.76% |
| FCF Yield | 2.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.
| Last Split Date | May 18, 2022 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
BioGaia AB has an Altman Z-Score of 25.58 and a Piotroski F-Score of 5.
| Altman Z-Score | 25.58 |
| Piotroski F-Score | 5 |